Impact of interleukin-27 on replication of hepatitis C virus

References

• World Health Organization. Hepatitis C (online fact sheet). Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Geneva, Switzerland; Jun 2011.
   Google Scholar
• Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47–52.
   PubMedGoogle Scholar
• Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497–1505.
   PubMed Web of Science ®Google Scholar
• Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics. 2000;5(3):129–151.
   PubMedGoogle Scholar
• Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU. A prokariotic-like mode of cytoplasmatic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 1998;12(1):67–83.
   PubMed Web of Science ®Google Scholar
• Dubuisson J. Hepatitis C virus proteins. World J Gastroenterol. 2007;13(17):2406–2415.
   PubMed Web of Science ®Google Scholar
• Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of sybtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74(Pt 11):2391–2399.
   PubMedGoogle Scholar
• NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consensus and State-of-the-Science Statements. 2002;19(3):1–46. Available at: http://consensus.nih.gov/2002/2002HepatitisC2002116 html.htm. Accessed October 26, 2011.
   Google Scholar
• Simmonds P. Genetic diversity and evolution of hepatitis C virus – 15 years on. J Gen Virol. 2004;85(Pt 11):3173–3188.
   PubMedGoogle Scholar
• Laskus T, Wang LF, Radkowski M, et al. Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol. 2001;75(5):2059–2066.
   Web of Science ®Google Scholar
• EASL International Consensus Conference on Hepatitis C, Paris 26–28, February 1999, consensus statement. J Hepatol.1999;30(5):956–961.
   Google Scholar
• Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52.
   PubMed Web of Science ®Google Scholar
• Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194(10):1395–1406.
   PubMed Web of Science ®Google Scholar
• Farci P, Alter HJ, Wong D, et al. A long term study of hepatitis C virus replication in non-A non-B hepatitis. N Engl J Med. 1991 ;325(2):98–104.
   Web of Science ®Google Scholar
• Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med. 1996;335(9):631–634.
   Web of Science ®Google Scholar
• Franguel L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol. 1996;25(4):427–432.
   Web of Science ®Google Scholar
• Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29(2):328–333.
   Web of Science ®Google Scholar
• Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;30(4):1059–1063.
   PubMed Web of Science ®Google Scholar
• Sheikh MY, Choi J, Quadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology. 2008;47(6):2127–2133.
   PubMed Web of Science ®Google Scholar
• Poustchi H, Negro F, Hui J, et al. Insulin resistence and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. J Hepatol. 2008;48(1):28–34.
   PubMed Web of Science ®Google Scholar
• Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine. 2006;73(6):633–638.
   Web of Science ®Google Scholar
• Carrozzo M, Quadri R, Latorre P, et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol. 2002;37(3):364–369.
   Web of Science ®Google Scholar
• Smyth CM, McKiernan SM, Hagan R, et al. Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02. Eur J Gastroenterol Hepatol. 2007;19(6):493–498.
   Web of Science ®Google Scholar
• Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Th1/Th2 cytokine imbalance in patients with Sjogren syndrome secondary to hepatitis C virus infection. Semin Arthritis Rheum. 2002;32(1):56–63.
   Web of Science ®Google Scholar
• O’Reilly FM, Darby C, Fogarty J, et al. Porphyrin metabolism in hepatitis C infection. Photodermatol Photoimmunol Photomed. 1996;12(1):31–33.
   Web of Science ®Google Scholar
• Weissenbom K, Ennen JC, Bokemeyer M, et al. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut. 2006;55(11):1624–1630.
   Web of Science ®Google Scholar
• Batten M, Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med. 2007;85(7):661–672.
   Web of Science ®Google Scholar
• Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16(6):779–790.
   PubMed Web of Science ®Google Scholar
• Sprecher CA, Grant F, Baumgartner JW, et al. Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun. 1998;246(1):82–90.
   Web of Science ®Google Scholar
• Noriko M, Izuru M, Masae O, et al. A pivotal role for Interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol. 2010;2010:605483.
   Google Scholar
• Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002;2(4):251–262.
   PubMed Web of Science ®Google Scholar
• Bender H, Wiesinger MY, Nordhoff C, et al. Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes. Hepatology. 2009;50(2):585–591.
   PubMed Web of Science ®Google Scholar
• Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN a signal via STAT1 and STAT3 and induce T-bet and IL-12R-beta-2 in naive T cells. J Interferon Cytokine Res. 2003;23(9):513–522.
   PubMed Web of Science ®Google Scholar
• Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Production of IL-27 and other IL-12 family cytochines by microglia and their subpopulations. Brain Res. 2005;1040(1–2):202–207.
   PubMed Web of Science ®Google Scholar
• Devergne O, Hummel M, Koeppen H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70(2):1143–1153.
   Web of Science ®Google Scholar
• Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol. 2004;172(4):2225–2231.
   PubMed Web of Science ®Google Scholar
• Larousserie F, Charlot P, Bardel E, et al. Differential effects of IL-27 on human B cell subsets. J Immunol. 2006;176:5890–5897.
   Web of Science ®Google Scholar
• Ruckerl D, Hessmann M, Yoshimoto T, et al. Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology. 2006;211:427–436.
   Web of Science ®Google Scholar
• Villarino AV Larkin J 3rd, Saris CJ, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;174:7684–7691.
   PubMed Web of Science ®Google Scholar
• Leonard WJ, O’Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293–322.
   PubMed Web of Science ®Google Scholar
• Takeda A, Hamano S, Yamanaka A, et al. Cutting edge: role of IL-27/ WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol. 2003;170(10):4886–4890.
   Web of Science ®Google Scholar
• Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001;13(2):211–217.
   PubMed Web of Science ®Google Scholar
• Cook JR, Jung V, Schwartz B, Wang P, Pestka S. Structural analysis of the human interferon gamma receptor: a small segment of the intracellular domain is specifically required for class I major histocompatibility complex antigen induction and antiviral activity. Proc Natl Acad Sci U SA. 1992;89(23):11317–11321.
   Web of Science ®Google Scholar
• Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J.1998;334(Pt 2):297–314.
   Google Scholar
• Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 2003;100(25):15047–15052.
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133–146.
   PubMed Web of Science ®Google Scholar
• Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages with IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715–725.
   PubMed Web of Science ®Google Scholar
• Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol. 2000;30(4):1113–1119.
   PubMed Web of Science ®Google Scholar
• Imamichi T, Yang J, Huang DW, et al. IL-27, a novel anti-HIV cytokine, activates multiple interferon inducible genes in macrophages. AIDS. 2008;22(1):39–45.
   Web of Science ®Google Scholar
• Fakruddin JM, Lempicki RA, Gorelick RJ, et al. Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood. 2007;109(5):1841–1849.
   Web of Science ®Google Scholar
• Zeuzem S. Interferon-based therapy for chronic hepatitis C: current and future perspectives. Nat Clin Pract Gastroenterol Hepatol. 2008;5(11):610–622.
   Google Scholar
• Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(4): 1100.
   Web of Science ®Google Scholar
• Bender H, Wiesinger MY, Nordhoff C, et al. Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes. Hepatology. 2009;50(2):585–591.
   PubMed Web of Science ®Google Scholar
• Galligan CL, Murooka TT, Rabbar R, Baig E, Majchrzak-Kita B, Fish EN. Interferons and viruses: signalling for supremacy. Immunol Res. 2006;35(1–2):27–40.
   Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10(1):76–99.
   PubMed Web of Science ®Google Scholar
• Frank AC, Zhang X, Katsounas A, Bharucha JP, Kottilil S, Imamichi T. Interleukin-27, an Anti-HIV-1 Cytokine, Inhibits Replication of Hepatitis C Virus. J Interferon Cytokine Res. 2010;30(6):427–431.
   Web of Science ®Google Scholar
• Boulay JL, O’Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity. 2003;19(2):159–163.
   PubMed Web of Science ®Google Scholar
• Carl JW, Bai XF IL-27: its roles in the induction and inhibition of inflammation. Int J Clin Exp Pathol. 2008;1(2):117–123.
   Web of Science ®Google Scholar
• Villarino AV Huang E, Hunter CA. Understanding the pro- and antiinflammatory properties of IL-27. J Immunol. 2004;173(2):715–720.
   PubMed Web of Science ®Google Scholar